The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Direct effects of thyroid hormones on hepatic lipid metabolism
Open accessAbstract
It has been known for a long time that thyroid hormones have prominent effects on hepatic fatty acid and cholesterol synthesis and metabolism. Indeed, hypothyroidism has been associated with increased serum levels of triglycerides and cholesterol as well as non-alcoholic fatty liver disease (NAFLD). Advances in areas such as cell imaging, autophagy and metabolomics have generated a more detailed and comprehensive picture of thyroid-hormone-mediated regulation of hepatic lipid metabolism at the molecular level. In this Review, we describe and summarize the key features of direct thyroid hormone regulation of lipogenesis, fatty acid β-oxidation, cholesterol synthesis and the reverse cholesterol transport pathway in normal and altered thyroid hormone states. Thyroid hormone mediates these effects at the transcriptional and post-translational levels and via autophagy. Given these potentially beneficial effects on lipid metabolism, it is possible that thyroid hormone analogues and/or mimetics might be useful for the treatment of metabolic diseases involving the liver, such as hypercholesterolaemia and NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Thyroid Hormone Receptors: Multiple Forms, Multiple Possibilities*
LAZAR, M. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-184 · Cited by 1,071
The Syndromes of Resistance to Thyroid Hormone*
REFETOFF, S., WEISS, R. E., & USALA, S. J. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-3-348 · Cited by 873
Duntas, L. H. (2002) · Thyroid · doi:10.1089/10507250252949405 · Cited by 725
Transcriptional regulation of hepatic lipogenesis
Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4074 · Cited by 646
Hypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
Nongenomic actions of thyroid hormone
Davis, P. J., Goglia, F., & Leonard, J. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.205 · Cited by 465
NAFLD and liver transplantation: Current burden and expected challenges
Pais, R., Barritt, A. S., Calmus, Y., Scatton, O., Runge, T., Lebray, P., Poynard, T., Ratziu, V., & Conti, F. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.033 · Cited by 430
Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia
Liu, H.-Y., Han, J., Cao, S. Y., Hong, T., Zhuo, D., Shi, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033936 · Cited by 352
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Ladenson, P. W., Kristensen, J. D., Ridgway, E. C., Olsson, A. G., Carlsson, B., Klein, I., Baxter, J. D., & Angelin, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905633 · Cited by 338
Lysosomal acid lipase deficiency – An under-recognized cause of dyslipidaemia and liver dysfunction
Reiner, Ž., Guardamagna, O., Nair, D., Soran, H., Hovingh, K., Bertolini, S., Jones, S., Ćorić, M., Calandra, S., Hamilton, J., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.04.003 · Cited by 314
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism
Chung, G. E., Kim, D., Kim, W., Yim, J. Y., Park, M. J., Kim, Y. J., Yoon, J.-H., & Lee, H.-S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.027 · Cited by 305
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy
Sinha, R. A., You, S.-H., Zhou, J., Siddique, M. M., Bay, B.-H., Zhu, X., Privalsky, M. L., Cheng, S.-Y., Stevens, R. D., Summers, S. A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60580 · Cited by 303
Self-citationOppenheimer, J. H., Schwartz, H. L., Lane, J. T., & Thompson, M. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114961 · Cited by 283
Insulin signalling mechanisms for triacylglycerol storage
Czech, M. P., Tencerova, M., Pedersen, D. J., & Aouadi, M. (2013) · Diabetologia · doi:10.1007/s00125-013-2869-1 · Cited by 276
Trost, S. U., Swanson, E., Gloss, B., Wang-Iverson, D. B., Zhang, H., Volodarsky, T., Grover, G. J., Baxter, J. D., Chiellini, G., Scanlan, T. S., et al. (2000) · Endocrinology · doi:10.1210/endo.141.9.7681 · Cited by 272
Erion, M. D., Cable, E. E., Ito, B. R., Jiang, H., Fujitaki, J. M., Finn, P. D., Zhang, B.-H., Hou, J., Boyer, S. H., van Poelje, P. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702759104 · Cited by 271
Shin, D.-J., & Osborne, T. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305417200 · Cited by 266
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
Baxter, J. D., & Webb, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2830 · Cited by 253
Cao, X., Kambe, F., Moeller, L. C., Refetoff, S., & Seo, H. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0093 · Cited by 246
Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.07.001 · Cited by 241
Self-citationKelly, M. J., Pietranico-Cole, S., Larigan, J. D., Haynes, N.-E., Reynolds, C. H., Scott, N., Vermeulen, J., Dvorozniak, M., Conde-Knape, K., Huang, K.-S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4019299 · Cited by 231
Martínez-Sánchez, N., Seoane-Collazo, P., Contreras, C., Varela, L., Villarroya, J., Rial-Pensado, E., Buqué, X., Aurrekoetxea, I., Delgado, T. C., Vázquez-Martínez, R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.014 · Cited by 231
Lysosome: regulator of lipid degradation pathways
Settembre, C., & Ballabio, A. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.06.006 · Cited by 229
Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study
Bano, A., Chaker, L., Plompen, E. P. C., Hofman, A., Dehghan, A., Franco, O. H., Janssen, H. L. A., Murad, S. D., & Peeters, R. P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1300 · Cited by 209
Sinha, R. A., Singh, B. K., Zhou, J., Wu, Y., Farah, B. L., Ohba, K., Lesmana, R., Gooding, J., Bay, B.-H., & Yen, P. M. (2015) · Autophagy · doi:10.1080/15548627.2015.1061849 · Cited by 209
Self-citationMolecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Cable, E. E., Finn, P. D., Stebbins, J. W., Hou, J., Ito, B. R., van Poelje, P. D., Linemeyer, D. L., & Erion, M. D. (2009) · Hepatology · doi:10.1002/hep.22572 · Cited by 206
Johansson, L., Rudling, M., Scanlan, T. S., Lundåsen, T., Webb, P., Baxter, J., Angelin, B., & Parini, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504379102 · Cited by 200
Lagrost, L. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90047-7 · Cited by 194
Finan, B., Clemmensen, C., Zhu, Z., Stemmer, K., Gauthier, K., Müller, L., De Angelis, M., Moreth, K., Neff, F., Perez-Tilve, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.014 · Cited by 191
Kim, D., Kim, W., Joo, S. K., Bae, J. M., Kim, J. H., & Ahmed, A. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.08.014 · Cited by 191
Davidson, N. O., Powell, L. M., Wallis, S. C., & Scott, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68263-8 · Cited by 190
Klieverik, L. P., Coomans, C. P., Endert, E., Sauerwein, H. P., Havekes, L. M., Voshol, P. J., Rensen, P. C. N., Romijn, J. A., Kalsbeek, A., & Fliers, E. (2009) · Endocrinology · doi:10.1210/en.2009-0297 · Cited by 183
Prevalence of hypothyroidism in nonalcoholic fatty liver disease
Pagadala, M. R., Zein, C. O., Dasarathy, S., Yerian, L. M., Lopez, R., & McCullough, A. J. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-2006-2 · Cited by 178
Non-alcoholic fatty liver disease in 2015
Ahmed, M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i11.1450 · Cited by 175
Hassan, M. M., Kaseb, A., Li, D., Patt, Y. Z., Vauthey, J.-N., Thomas, M. B., Curley, S. A., Spitz, M. R., Sherman, S. I., Abdalla, E. K., et al. (2009) · Hepatology · doi:10.1002/hep.22793 · Cited by 173
Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis?
Liangpunsakul, S., & Chalasani, N. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200310000-00014 · Cited by 167
Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature
Flamant, F., Cheng, S.-Y., Hollenberg, A. N., Moeller, L. C., Samarut, J., Wondisford, F. E., Yen, P. M., & Refetoff, S. (2017) · Endocrinology · doi:10.1210/en.2017-00250 · Cited by 165
Self-citationThyroid hormone-related regulation of gene expression in human fatty liver.
Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164
Non-alcoholic fatty liver disease and thyroid dysfunction: A systematic review
Eshraghian, A., & Jahromi, A. H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i25.8102 · Cited by 162
Hepatic Fatty Acid Trafficking: Multiple Forks in the Road
Mashek, D. G. (2013) · Advances in Nutrition · doi:10.3945/an.113.004648 · Cited by 160
Adams, A. C., Astapova, I. I., Fisher, F. M., Badman, M. K., Kurgansky, K. E., Flier, J. S., Hollenberg, A. N., & Maratos–Flier, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.107375 · Cited by 159
Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity
Yan, F., Wang, Q., Lu, M. H., Chen, W., Song, Y., Jing, F., Guan, Y., Wang, L., Lin, Y., Bo, T., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.037 · Cited by 156
Changes in Lipoprotein(a) Levels in Overt and Subclinical Hypothyroidism Before and During Treatment
Tzotzas, T., Krassas, G. E., Κωνσταντινίδης, Θ. Κ., & Bougoulia, M. (2000) · Thyroid · doi:10.1089/thy.2000.10.803 · Cited by 152
Nuclear Cytoplasmic Shuttling by Thyroid Hormone Receptors
Baumann, C. T., Maruvada, P., Hager, G. L., & Yen, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011112200 · Cited by 149
Self-citationCoordination of mitochondrial biogenesis by thyroid hormone
Weitzel, J. M., & Iwen, K. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.009 · Cited by 149
Ness, G. C., Pendleton, L. C., Li, Y. C., & Chiang, J. Y. L. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91568-d · Cited by 148
Thyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in rats
Perra, A., Simbula, G., Simbula, M., Pibiri, M., Kowalik, M. A., Sulas, P., Cocco, M. T., Ledda‐Columbano, G. M., & Columbano, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-108464 · Cited by 148
Regulation and Functions of Autophagic Lipolysis
Cingolani, F., & Czaja, M. J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.003 · Cited by 148
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor
Furuya, F., Hanover, J. A., & Cheng, S.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510849103 · Cited by 147
Crystal Structure of Human ZAG, a Fat-Depleting Factor Related to MHC Molecules
Sánchez, L. M., Chirino, A. J., & Björkman, P. J. (1999) · Science · doi:10.1126/science.283.5409.1914 · Cited by 142
3,5‐Diiodo‐ L ‐thyronine powerfully reduces adiposity in rats by increasing the burning of fats
Lanni, A., Moreno, M., Lombardi, A., De Lange, P., Silvestri, E., Ragni, M., Farina, P., Baccari, G. C., Fallahi, P., Antonelli, A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-3977fje · Cited by 134
Desvergne, B., Petty, K. J., & Nikodem, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35275-4 · Cited by 134
A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity
Underwood, A. H., Emmett, J. C., Ellis, D. A., Flynn, S. B., Leeson, P. D., Benson, G. M., Novelli, R., Pearce, N. J., & Shah, V. P. (1986) · Nature · doi:10.1038/324425a0 · Cited by 131
Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
Bonde, Y., Breuer, O., Lütjohann, D., Sjöberg, S., Angelin, B., & Rudling, M. J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m051664 · Cited by 120
Vatner, D. F., Weismann, D., Beddow, S. A., Kumashiro, N., Erion, D. M., Liao, X.-H., Grover, G. J., Webb, P., Phillips, K. J., Weiss, R. E., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00573.2012 · Cited by 119
Goldman, S., McCarren, M., Morkin, E., Ladenson, P. W., Edson, R., Warren, S., Ohm, J., Thai, H., Churby, L., Barnhill, J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.834424 · Cited by 117
Zhang, X., Song, Y., Feng, M., Zhou, X., Lu, Y., Gao, L., Yu, C., Jiang, X., & Zhao, J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m047654 · Cited by 117
EMIL-Study, T., Ludwig, U., Holzner, D., Denzer, C., Greinert, A., Haenle, M. M., Oeztuerk, S., Köenig, W., Boehm, B. O., Mason, R. A., et al. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0030-5 · Cited by 115
Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man.
Abrams, J. J., Grundy, S. M., & Ginsberg, H. N. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35374-8 · Cited by 112
Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis
Song, Y., Xu, C., Shao, S., Liu, J., Wanjia, X., Xu, J., Qin, C., Li, C., Hu, B., Yi, S., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.006 · Cited by 110
Activation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.001 · Cited by 109
Xu, C., Xu, L., Yu, C., Miao, M., & Li, Y. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04016.x · Cited by 108
Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats
de Lange, P., Cioffi, F., Senese, R., Moreno, M., Lombardi, A., Silvestri, E., De Matteis, R., Lionetti, L., Mollica, M. P., Goglia, F., et al. (2011) · Diabetes · doi:10.2337/db11-0207 · Cited by 106
Distinct Dysregulation of Lipid Metabolism by Unliganded Thyroid Hormone Receptor Isoforms
Araki, O., Ying, H., Zhu, X., Willingham, M. C., & Cheng, S.-Y. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0311 · Cited by 105
Lesmana, R., Sinha, R. A., Singh, B. K., Zhou, J., Ohba, K., Wu, Y., Yau, W. W. Y., Bay, B., & Yen, P. M. (2015) · Endocrinology · doi:10.1210/en.2015-1632 · Cited by 102
Self-citationBryzgalova, G., Effendic, S., Khan, A., Rehnmark, S., Barbounis, P., Boulet, J., Dong, G., Singh, R., Shapses, S., Malm, J., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.010 · Cited by 94
Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone
Thakran, S., Sharma, P., Attia, R. R., Hori, R. T., Deng, X., Elam, M. B., & Park, E. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437970 · Cited by 91
Bohinc, B. N., Michelotti, G. A., Xie, G., Pang, H., Suzuki, A., Guy, C. D., Piercy, D. L., Krüger, L., Swiderska‐Syn, M., Machado, M. V., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1302 · Cited by 89
Jackson‐Hayes, L., Song, S.-L., Lavrentyev, E. N., Jansen, M. S., Hillgartner, F., Tian, L., Wood, P. A., Cook, G., & Park, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211062200 · Cited by 88
Ness, G. C., & Lopez, D. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.0061 · Cited by 87
Hashimoto, K., Yamada, M., Matsumoto, S., Monden, T., Satoh, T., & Mori, M. (2006) · Endocrinology · doi:10.1210/en.2006-0116 · Cited by 86
Quiroga, A. D., & Lehner, R. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.007 · Cited by 86
Tseng, Y., Ke, P., Liao, C., Wu, S., Chi, H., Tsai, C., Chen, C., Lin, Y.-H., & Lin, K. (2013) · Autophagy · doi:10.4161/auto.26126 · Cited by 85
Holness, M. J., Bulmer, K., Smith, N. D., & Sugden, M. C. (2003) · Biochemical Journal · doi:10.1042/bj20021509 · Cited by 84
Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism
Taylor, A. H., Stephan, Z. F., Steele, R. E., & Wong, N. C. W. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.542 · Cited by 84
Liu, Y., Heymann, R. S., Moatamed, F., Schultz, J. J., Sobel, D., & Brent, G. A. (2006) · Endocrinology · doi:10.1210/en.2006-0836 · Cited by 81
Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway
Goldberg, I. J., Huang, L.-S., Huggins, L. A., Yu, S., Nagareddy, P. R., Scanlan, T. S., & Ehrenkranz, J. R. (2012) · Endocrinology · doi:10.1210/en.2012-1572 · Cited by 80
Radenne, A., Akpa, M. M., Martel, C., Sawadogo, S., Mauvoisin, D., & Mounier, C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90438.2008 · Cited by 79
Jornayvaz, F. R., Lee, H., Jurczak, M. J., Alves, T. C., Guebre‐Egziabher, F., Guigni, B. A., Zhang, D., Samuel, V. T., Silva, J. E., & Shulman, G. I. (2011) · Endocrinology · doi:10.1210/en.2011-1793 · Cited by 78
Augmented Hepatic and Skeletal Thyromimetic Effects of Tiratricol in Comparison with Levothyroxine
Sherman, S. I., Ringel, M. D., Smith, M. J., Kopelen, H. A., Zoghbi, W. A., & Ladenson, P. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2153 · Cited by 78
Hashimoto, K., Ishida, E., Matsumoto, S., Okada, S., Yamada, M., Satoh, T., Monden, T., & Mori, M. (2009) · Endocrinology · doi:10.1210/en.2009-0059 · Cited by 74
Grover, G. J., Mellström, K., & Malm, J. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2005.tb00161.x · Cited by 73
Frau, C., Loi, R., Petrelli, A., Perra, A., Menegon, S., Kowalik, M. A., Pinna, S., Leoni, V. P., Fornari, F., Gramantieri, L., et al. (2014) · Hepatology · doi:10.1002/hep.27399 · Cited by 72
Singh, B. K., Sinha, R. A., Zhou, J., Xie, S. Y., You, S.-H., Gauthier, K. C., & Yen, P. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504845 · Cited by 71
Self-citationThyroid hormones and treatment of obesity
Krotkiewski, M. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801294 · Cited by 69
Chng, C. L., Lim, A. Y., Tan, H. C., Kovalik, J., Tham, K. W., Bee, Y. M., Lim, W., Acharyya, S., Lai, O. F., Chong, S. C., et al. (2016) · Thyroid · doi:10.1089/thy.2015.0602 · Cited by 69
Self-citationIdentification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin, H., Cody, V., Davis, F. B., Hercbergs, A. A., Luidens, M. K., Mousa, S. A., & Davis, P. J. (2011) · PubMed · Cited by 68
Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD
Sinha, R. A., & Yen, P. M. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0113-7 · Cited by 68
Self-citationGökmen, F. Y., Ahbab, S., Ataoğlu, H. E., Türker, B. Ç., Çetin, F., Türker, F., Mamaç, R. Y., & Yenigün, M. (2016) · Clinics · doi:10.6061/clinics/2016(04)08 · Cited by 67
Yamauchi, M., Kambe, F., Cao, X., Lu, X., Kozaki, Y., Oiso, Y., & Seo, H. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0249 · Cited by 65
Hypothalamic effects of thyroid hormones on metabolism
Martínez‐Sánchez, N., Álvarez, C. V., Fernø, J., Nogueiras, R., Diéguez, C., & López, M. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.04.004 · Cited by 64
Direct effects of iodothyronines on excess fat storage in rat hepatocytes
Grasselli, E., Voci, A., Canesi, L., Matteis, R. D., Goglia, F., Cioffi, F., Fugassa, E., Gallo, G., & Vergani, L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.027 · Cited by 64
Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects
Yang, T., Gu, H., Wu, J., & Sui, J. H. (2014) · Endocrine Research · doi:10.3109/07435800.2014.952014 · Cited by 62
Fatty Acyl-CoAs Are Potent Inhibitors of the Nuclear Thyroid Hormone Receptor In Vitro
Li, Q., Yamamoto, N., Inoue, A., & Morisawa, S. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123111 · Cited by 61
Zhang, Y., Yin, L., & Hillgartner, F. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005894200 · Cited by 61
Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs
Chan, I. H., & Privalsky, M. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209389 · Cited by 60
Liver X Receptor-α Gene Expression Is Positively Regulated by Thyroid Hormone
Hashimoto, K., Matsumoto, S., Yamada, M., Satoh, T., & Mori, M. (2007) · Endocrinology · doi:10.1210/en.2007-0150 · Cited by 60
3,5,3′triiodo‐L‐thyronine induces SREBP‐1 expression by non‐genomic actions in human HEP G2 cells
Gnoni, G. V., Rochira, A., Leone, A., Damiano, F., Marsigliante, S., & Siculella, L. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22974 · Cited by 60
Yen, C.-C., Huang, Y., Liao, C.-Y., Liao, C.-J., Cheng, W., Chen, W.-J., & Lin, K. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01911 · Cited by 60
NCoR1 and SMRT Play Unique Roles in Thyroid Hormone Action In Vivo
Shimizu, H., Astapova, I. I., Ye, F., Bilban, M., Cohen, R., & Hollenberg, A. N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01208-14 · Cited by 60
Singh, B. K., Sinha, R. A., Zhou, J., Tripathi, M., Ohba, K., Wang, M., Astapova, I. I., Ghosh, S., Hollenberg, A. N., Gauthier, K. C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668673 · Cited by 58
Self-citationJekabsons, M. B., Gregoire, F. M., SCHONFELD-WARDEN, N. A., Warden, C. H., & Horwitz, B. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.2.e380 · Cited by 58
Non-classic thyroid hormone signalling involved in hepatic lipid metabolism
Cordeiro, A., Souza, L. L., Einicker‐Lamas, M., & Pazos-Moura, C. C. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0542 · Cited by 57
Chamba, A., Neuberger, J., Strain, A., Hopkins, J., Sheppard, M. C., & Franklyn, J. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550778 · Cited by 55
Iannucci, L. F., Cioffi, F., Senese, R., Goglia, F., Lanni, A., Yen, P. M., & Sinha, R. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-02205-1 · Cited by 54
Self-citationTancevski, I., Demetz, E., Eller, K., Duwensee, K., Hoefer, J., Heim, C., Stanzl, U., Wehinger, A., Auer, K., Karer, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008722 · Cited by 53
LONG-TERM EFFECT OF DRIED THYROID ON SERUM-LIPOPROTEIN AND SERUM-CHOLESTEROL LEVELS
Gofman, J., Strisower, B., Rubinger, J. H., Guzvich, P., Galioni, E. F., & Pouteau, J. (1957) · The Lancet · doi:10.1016/s0140-6736(57)90199-x · Cited by 53
Thyroid hormones, mitochondrial bioenergetics and lipid handling
Cioffi, F., Lanni, A., & Goglia, F. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833cf354 · Cited by 53
Bonde, Y., Plösch, T., Kuipers, F., Angelin, B., & Rudling, M. J. (2012) · Hepatology · doi:10.1002/hep.25861 · Cited by 52
Grasselli, E., Voci, A., Canesi, L., Goglia, F., Ravera, S., Panfoli, I., Gallo, G., & Vergani, L. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0074 · Cited by 52
Thyroid hormone analogues and derivatives: Actions in fatty liver
Coppola, M., Glinni, D., Moreno, M., Cioffi, F., Silvestri, E., & Goglia, F. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i3.114 · Cited by 51
Fringes, B., & Reith, A. (1982) · PubMed · Cited by 51
Fonseca, T. L., Fernandes, G. W., McAninch, E. A., Bocco, B. M. L. C., Abdalla, S. M., Ribeiro, M. O., Mohácsik, P., Fekete, C., Li, D., Xing, X., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508943112 · Cited by 48
Świerczyński, J., Mitchell, D. A., Reinhold, D., Salati, L. M., Stapleton, S. R., Klautky, S. A., Struve, A., & Goodridge, A. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47395-x · Cited by 46
Ito, B., Zhang, B. L., Cable, E. E., Song, X., Fujitaki, J., MacKenna, D., Wilker, C., Chi, B., Poelje, P. V., Linemeyer, D., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1750-3639.2009.00038.x · Cited by 46
Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver
Yao, X., Hou, S., Zhang, D., Xia, H., Wang, Y., Jiang, J., Yin, H., & Ying, H. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-38 · Cited by 46
Cellular Action of Thyroid Hormone
Sinha, R. A., & Yen, P. M. (2014) · Cited by 45
Self-citationCampbell, M. C., Anderson, G. W., & Mariash, C. N. (2003) · Endocrinology · doi:10.1210/en.2002-0008 · Cited by 41
Rat Liver Peroxisomes, II. Stimulation of Peroxisomal Fatty-Acid β-Oxidation by Thyroid Hormones
Just, W. W., & Hartl, F. U. (1983) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1983.364.2.1541 · Cited by 41
Sobetirome: the past, present and questions about the future
Lindemann, J. A. L., & Webb, P. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1090429 · Cited by 38
Thyroid Hormone Levels in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease
Torun, E., Özgen, İ. T., Gökçe, S., Aydın, S. G., & Cesur, Y. (2014) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1155 · Cited by 37
Effect of long-term high-fat feeding on energy balance and liver oxidative activity in rats
Iossa, S., Lionetti, L., Mollica, M. P., Crescenzo, R., Barletta, A., & Liverini, G. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001665 · Cited by 37
Brenta, G., Berg, G. A., Miksztowicz, V., Lopez, G. I., Lucero, D., Faingold, C., Murakami, M., Machima, T., Nakajima, K., & Schreier, L. E. (2016) · Thyroid · doi:10.1089/thy.2015.0140 · Cited by 37
3,5-Diiodo-L-Thyronine Modifies the Lipid Droplet Composition in a Model of Hepatosteatosis
Grasselli, E., Voci, A., Canesi, L., Salis, A., Damonte, G., Compalati, A. D., Goglia, F., Gallo, G., & Vergani, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356674 · Cited by 36
Grasselli, E., Voci, A., Demori, I., Vecchione, G., Compalati, A. D., Gallo, G., Goglia, F., Matteis, R. D., Silvestri, E., & Vergani, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00418 · Cited by 36
Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges
Elbers, L. P. B., Kastelein, J. J. P., & Sjouke, B. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0564-7 · Cited by 36
Moon, J. H., Kim, H. J., Kim, H. M., Choi, S. H., Lim, S. K., Park, Y. J., Jang, H. C., & Soo, B. (2013) · Thyroid · doi:10.1089/thy.2012.0457 · Cited by 35
Cavallo, A., Priore, P., Gnoni, G. V., Papa, S., Zanotti, F., & Gnoni, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052328 · Cited by 33
Regulation of hepatic level of fatty-acid-binding protein by hormones and clofibric acid in the rat
Nakagawa, S., Kawashimà, Y., Hirose, A., & Kozuka, H. (1994) · Biochemical Journal · doi:10.1042/bj2970581 · Cited by 31
Djouadi, F., Riveau, B., Merlet-Bénichou, C., & Bastin, J. (1997) · Biochemical Journal · doi:10.1042/bj3240289 · Cited by 31
Thyroid hormone. Basis for its hypocholesterolemic effect.
Ness, G. C. (1991) · PubMed · Cited by 31
Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood
Santana‐Farré, R., de Mirecki-Garrido, M., Bocos, C., Henríquez‐Hernández, L. A., Kahlon, N., Herrera, E., Norstedt, G., Parini, P., Flores‐Morales, A., & Fernández‐Pérez, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037386 · Cited by 28
zu Schwabedissen, H. E. M., Ware, J. A., Finkelstein, D., Chaudhry, A. S., Mansell, S. E., Leon‐Ponte, M., Strom, S. C., Zaher, H., Schwarz, U. I., Freeman, D. J., et al. (2011) · Hepatology · doi:10.1002/hep.24391 · Cited by 28
Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells
Kihara, S., Wölle, J., Ehnholm, C., Chan, L., & Oka, K. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39682-6 · Cited by 28
Age-related changes in the responsiveness of apolipoprotein A1 to thyroid hormone
Mooradian, A. D., Wong, N. C., & Shah, G. N. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.6.r1602 · Cited by 27
Hashimoto, K., Ishida, E., Miura, A., Ozawa, A., Shibusawa, N., Satoh, T., Okada, S., Yamada, M., & Mori, M. (2012) · Endocrinology · doi:10.1210/en.2012-1559 · Cited by 25
The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice
Kannisto, K., Rehnmark, S., Slätis, K., Webb, P., Larsson, L., Gåfvels, M. E., Eggertsen, G., & Parini, P. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.035 · Cited by 23
Goudonnet, H., Magdalou, J., Mounie, J., Naoumi, A., Viriot, M., Escousse, A., Siest, G., & Truchot, R. (1990) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(90)90167-u · Cited by 23
Lipid lowering effects of iodothyronines:In vivoandin vitrostudies on rat liver
Vergani, L. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.169 · Cited by 16
Gnocchi, D., Massimi, M., Alisi, A., Incerpi, S., & Bruscalupi, G. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1371858 · Cited by 15
Thyroid Hormone Upregulates Zinc-α2-glycoprotein Production in the Liver but Not in Adipose Tissue
Simó, R., Hernández, C., Sáez‐López, C., Soldevila, B., Puig‐Domingo, M., & Selva, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085753 · Cited by 13
3,5-diiodo-L-thyronine: A Possible Pharmacological Agent?
Coppola, M., Cioffi, F., Moreno, M., Goglia, F., & Silvestri, E. (2016) · Current Drug Delivery · doi:10.2174/1567201813666151123124340 · Cited by 13
The Direct Tri-Iodothyronine Mitochondrial Pathway: Science Or Mythology?
Wrutniak‐Cabello, C., Casas, F., & Cabello, G. (2000) · Thyroid · doi:10.1089/thy.2000.10.965 · Cited by 10
Research works printed but not linked: 9
- Dang, A. Q., Faas, F. H. & Carter, W. J. Influence of hypo- and hyperthyroidism on rat liver glycerophospholipid metabolism. Lipids 20, 897–902 (1985). · doi:10.1007/bf02534774
- Babenko, N. A. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver. Med. Sci. Monit. 11, BR131–BR138 (2005).
- Bucki, R., Gorska, M., Zendzian-Piotrowska, M. & Gorski, J. Effect of triiodothyronine on the content of phospholipids in the rat liver nuclei. J. Physiol. Pharmacol. 51, 535–540 (2000).
- Takeda, T. et al. Regulation of rat hepatic peroxisomal enoyl-CoA hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme by thyroid hormone. Biochem. Biophys. Res. Commun. 185, 211–216 (1992). · doi:10.1016/s0006-291x(05)80977-5
- Just, W. W., Hartl, F. U. & Schimassek, H. Rat liver peroxisomes. I. New peroxisome population induced by thyroid hormones in the liver of male rats. Eur. J. Cell Biol. 26, 249–254 (1982).
- Goglia, F., Liverini, G., Lanni, A., Iossa, S. & Barletta, A. Effects of 3,5,3′-triiodothyronine (T3) on rat liver peroxisomal compartment during cold exposure. Exp. Biol. 48, 135–140 (1989).
- Yap, C. S., Sinha, R. A., Ota, S., Katsuki, M. & Yen, P. M. Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells. Biochem. Biophys. Res. Commun. 440, 635–639 (2013).This study highlights the potential role of miRNA in thyroid-hormone-regulated cholesterol metabolism. · DOI
- Nakamura, H., Rue, P. A. & DeGroot, L. J. Thyroid hormone increases type I adenosine 3′, 5′-monophosphate-dependent protein kinase and casein kinase activities in rat liver cytosol: analysis of protein kinases by polyacrylamide disc gel electrophoresis. Endocrinology 112, 1427–1433 (1983). · doi:10.1210/endo-112-4-1427
- Tancevski, I., Demetz, E. & Eller, P. Sobetirome: a selective thyromimetic for the treatment of dyslipidemia. Recent Pat. Cardiovasc. Drug Discov. 6, 16–19 (2011). · doi:10.2174/157489011794578473
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Ferguson, D., & Finck, B. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00507-z · Cited by 504
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome
Laclaustra, M., Moreno-Franco, B., Lou-Bonafonte, J. M., Mateo-Gallego, R., Casasnovas, J. A., Guallar-Castillon, P., Cenarro, A., & Civeira, F. (2019) · Diabetes Care · doi:10.2337/dc18-1410 · Cited by 322
Metadata
- Authors
- Sinha, R. A., Singh, B. K., & Yen, P. M.
- Venue
- Nature Reviews Endocrinology
- Published
- 2018-02-23
- Volume
- 14
- Issue
- 5
- Pages
- 259-269
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2787895864
- Cited by
- 660
- References
- 149
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.